SLC29A1 and pancreatic ductal adenocarcinoma: Indeed, experimental evidence indicates a significant correlation between gemcitabine chemotherapy outcome and human equilibrative nucleoside transporter-1 (hENT1) gene expression in pancreatic ductal adenocarcinoma [12].